Hui Liu - 24 May 2022 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
24 May 2022
Net transactions value
$0
Form type
4
Filing time
26 May 2022, 20:13:02 UTC
Previous filing
06 Apr 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +2,240 $0.000000 2,240 24 May 2022 Common Stock 2,240 $12.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 24, 2023 or the date of the Company's 2023 Annual Meeting of Stockholders.